GGrantIndex
Sort

50,496 grants matching lung cancer

Genetic Epidemiology of Cancer

$746,567
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2016 · HG

Clinical Trial of the Fit Families Multicomponent Obesity Intervetnion for African American Adolescents and Their Caregivers: Next Step from the ORBIT Initiative

$746,364
Phillippe Belton Cunningham · Medical University Of South Carolina · R33 · FY2022 · HL

Development of Drugs Acting at Adenosine Receptors

$745,815
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Fluorescence-based sequence-specific imaging of RNA modifications

$745,796
Ling Tian · Mediomics, Llc · R44 · FY2024 · GM

NanoDisk-Amphotericin B therapy for aspergillosis

$745,652
Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2011 · AI

Protein Tyrosine Dephosphorylation & Signal Transduction

$745,634
Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2014 · CA

Characterization and Genetics of KI toxicity in iPSC-derived cardiomyocytes

$745,632
Ulrich Broeckel · Medical College Of Wisconsin · R01 · FY2019 · HL

Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

$745,442
C. Noel Bairey Merz · Cedars-Sinai Medical Center · R01 · FY2010 · HL

Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind)

$745,427
Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2020 · AG

Trial of a harm reduction strategy for people with HIV who smoke cigarettes

$745,331
Jonathan Shuter · Albert Einstein College Of Medicine · R01 · FY2023 · CA

Understanding omega-3 and 6 fatty acid dependent regulation of inflammatory signals in pancreatic cancer

$745,320
Susan M Kaech · Salk Institute For Biological Studies · U01 · FY2025 · CA

Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants

$745,315
Laura Jean Bierut · Washington University · R01 · FY2014 · DA

Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping

$745,169
Han Zhu · Stanford University · R01 · FY2025 · HL

Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS

$745,162
John V Frangioni · Curadel, Llc · R01 · FY2020 · CA

Columbus NCORP RFA-CA-18-016

$745,063
Timothy David Moore · Columbus Community Clinical Oncology Prg · UG1 · FY2019 · CA

NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER

$745,015
Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2018 · CA

Onco-primary care networking to support TEAM-based care - the ONE TEAM Study

$744,941
Kevin Charles Oeffinger · Duke University · R01 · FY2023 · CA

PROMINENT - Stanford

$744,867
Emma Lundberg · Stanford University · OT2 · FY2023 · CA

Identification of synthetic lethal interactors in pancreatic cancer

$744,708
Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2015 · CA

Informatics Tools for Optimized Imaging Biomarkers for Cancer Research&Discovery

$744,624
Bruce R Rosen · Massachusetts General Hospital · U24 · FY2014 · CA

Assessing the integration of tobacco cessation treatment into lung cancer screening

$744,556
Elyse R Park · Massachusetts General Hospital · R01 · FY2021 · CA

Epidemiology of Venous Thrombosis and Pulmonary Embolism

$744,532
Weihong Tang · University Of Minnesota · R01 · FY2023 · HL

DNA evaluation of fragments for early interception (DELFI) of Lung cancer

$744,514
Victor E Velculescu · Johns Hopkins University · U01 · FY2023 · CA

Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women

$744,389
Joan M Lappe · Creighton University · R01 · FY2012 · CA

Tumor stem cells and metastatic outcomes in mouse models of prostate cancer

$744,376
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA